Erythropoietin (EPO) is a therapeutic product of recombinant DNA technology and it has
been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of …

The well-established physiological function of erythropoietin (EPO) is the induction of
erythropoiesis. A growing body of evidence indicates that EPO has tissue-protective effects …

Erythropoietin (EPO), a glycoprotein essential for red blood cell production acts on several
non-erythropoietic tissues. The EPO receptor (EPOR) is expressed in a variety of cell types …

Erythropoietin (EPO) is a principal regulator that promotes proliferation and terminal
differentiation of erythroid progenitor cells. EPO receptors are expressed not only in …

Since the isolation and purification of erythropoietin (EPO) in 1977, the essential role of EPO
for mature red blood cell production has been well established. The cloning of the EPO gene …

Erythropoietin (EPO) is a 30,400 daltons glycoprotein, consisting of 165 amino acids
produced mainly in the kidney and in the liver and regulating erythrocyitosis. It primarily acts …

Erythropoietin (Epo) was once thought to act exclusively in the formation of red blood cells.
As recently reviewed by Smith et al.[Cardiovasc. Res. 59 (2003) 538–548], Epo can also act …

Traditionally, erythropoietin (EPO) is described as a hematopoietic cytokine, regulating
proliferation and differentiation and survival of the erythroid progenitors. The recent finding …

Erythropoietin (Epo) has been thought to act exclusively on erythroid progenitor cells. The
identification of Epo receptor (EpoR) in non-haematopoietic cells and tissues including …

Erythropoietin is a hormone produced by the kidney, which regulates proliferation,
differentiation and maturation of red cells. Recombinant human EPO (rH-EPO) is well known …